These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 705273)

  • 1. Fibrodysplasia ossificans progressiva. Biochemical changes in blood serum, urine, skin, bone, and ectopic ossification.
    Blumenkrantz N; Asboe-Hansen G
    Scand J Rheumatol; 1978; 7(2):85-9. PubMed ID: 705273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrodysplasia (myositis) ossificans progressiva treated with disodium etidronate.
    Hentzer B; Jacobsen HH; Asboe-Hansen G
    Clin Radiol; 1978 Jan; 29(1):69-75. PubMed ID: 414874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical analysis of dermis and urine in generalized scleroderma.
    Blumenkrantz N; Asboe-Hansen G
    Acta Derm Venereol; 1980; 60(2):115-18. PubMed ID: 6155015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia ossificans progressiva.
    Brantus JF; Meunier PJ
    Clin Orthop Relat Res; 1998 Jan; (346):117-20. PubMed ID: 9577418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
    Krane SM; Kantrowitz FG; Byrne M; Pinnell SR; Singer FR
    J Clin Invest; 1977 May; 59(5):819-27. PubMed ID: 404321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
    Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
    J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of bone and cartilage related genes in fibrodysplasia ossificans progressiva, myositis ossificans traumatica, and osteogenic sarcoma.
    Shafritz AB; Kaplan FS
    Clin Orthop Relat Res; 1998 Jan; (346):46-52. PubMed ID: 9577409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice.
    Kawao N; Yano M; Tamura Y; Okumoto K; Okada K; Kaji H
    J Bone Miner Metab; 2016 Sep; 34(5):517-25. PubMed ID: 26204847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trial.
    Kitoh H; Achiwa M; Kaneko H; Mishima K; Matsushita M; Kadono I; Horowitz JD; Sallustio BC; Ohno K; Ishiguro N
    Orphanet J Rare Dis; 2013 Oct; 8():163. PubMed ID: 24131551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva.
    Ahn J; Feldman G; Terry L; Shore EM; Kaplan FS
    Clin Orthop Relat Res; 2003 Jan; (406):205-13. PubMed ID: 12579020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyproline and hydroxylysine in different tissues of human embryos.
    Blumenkrantz N; Asboe-Hansen G
    Mech Ageing Dev; 1975; 4(3-4):281-7. PubMed ID: 1195787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva.
    Gannon FH; Kaplan FS; Olmsted E; Finkel GC; Zasloff MA; Shore E
    Hum Pathol; 1997 Mar; 28(3):339-43. PubMed ID: 9042799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of thyroid hormones on collagen content in tissues of guinea pigs.
    Drózdzm M; Kucharz E; Grucka-Mamczar E
    Endokrinologie; 1979 Feb; 73(1):105-11. PubMed ID: 467355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva.
    Ravazzolo R; Cappato S; Bocciardi R
    Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic calcaneal ossification: an additional early radiographic finding in infants with fibrodysplasia ossificans progressiva.
    Hasegawa S; Victoria T; Kayserili H; Zackai E; Nishimura G; Haga N; Nakashima Y; Miyazaki O; Kitoh H
    Pediatr Radiol; 2016 Oct; 46(11):1568-72. PubMed ID: 27492340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of TGFβ signaling decreases osteogenic differentiation of fibrodysplasia ossificans progressiva fibroblasts in a novel in vitro model of the disease.
    Micha D; Voermans E; Eekhoff MEW; van Essen HW; Zandieh-Doulabi B; Netelenbos C; Rustemeyer T; Sistermans EA; Pals G; Bravenboer N
    Bone; 2016 Mar; 84():169-180. PubMed ID: 26769004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary metabolites of collagen.
    Segrest JP
    Methods Enzymol; 1982; 82 Pt A():398-410. PubMed ID: 7078445
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva.
    Lanchoney TF; Olmsted EA; Shore EM; Gannon FA; Rosen V; Zasloff MA; Kaplan FS
    Clin Orthop Relat Res; 1998 Jan; (346):38-45. PubMed ID: 9577408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel studies on collagen hydroxyproline and hydroxylysine in human skin biopsies.
    Blumenkrantz N; Ullman S; Asboe-Hansen G
    Acta Derm Venereol; 1976; 56(2):93-8. PubMed ID: 58530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemical and ultrastructural studies in fibrodysplasia ossificans progressiva (myositis ossificans progressiva).
    Maxwell WA; Spicer SS; Miller RL; Halushka PV; Westphal MC; Setser ME
    Am J Pathol; 1977 Jun; 87(3):483-98. PubMed ID: 141214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.